{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:01:49Z","timestamp":1774015309214,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch Hsin-Chu Hospital","doi-asserted-by":"publisher","award":["111-HCH102"],"award-info":[{"award-number":["111-HCH102"]}],"id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch Hsin-Chu Hospital","doi-asserted-by":"publisher","award":["106-HCH024"],"award-info":[{"award-number":["106-HCH024"]}],"id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch Hsin-Chu Hospital","doi-asserted-by":"publisher","award":["109-HCH108"],"award-info":[{"award-number":["109-HCH108"]}],"id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch Hsin-Chu Hospital","doi-asserted-by":"publisher","award":["112-HCH073"],"award-info":[{"award-number":["112-HCH073"]}],"id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023544","name":"National Taiwan University Hospital Hsin-Chu Branch Hsin-Chu Hospital","doi-asserted-by":"publisher","award":["110-HCH074"],"award-info":[{"award-number":["110-HCH074"]}],"id":[{"id":"10.13039\/501100023544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.abb.2026.110762","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:07:45Z","timestamp":1770656865000},"page":"110762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["EGFR and IRE1\u03b1 pathways are associated with distinct immunomodulatory gene expression profiles in NSCLC cells with acquired resistance to EGFR TKIs"],"prefix":"10.1016","volume":"779","author":[{"given":"Yi-Shiuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Chuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Chi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li\u2010Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ru","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1882-4986","authenticated-orcid":false,"given":"Hong-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.18632\/oncotarget.13815","article-title":"Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions","volume":"8","author":"Kuan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.abb.2026.110762_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.abb.2026.110762_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.abb.2026.110762_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S2213-2600(23)00135-2","volume":"11","author":"Lu","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.abb.2026.110762_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1200\/JCO.23.01891","article-title":"Phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR- or ALK-mutated non-small-cell lung cancer (ATTLAS, KCSG-LU19-04)","volume":"42","author":"Park","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.abb.2026.110762_bib6","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","article-title":"Cancer cell-intrinsic mechanisms driving acquired immune tolerance","volume":"56","author":"Ghorani","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.abb.2026.110762_bib7","article-title":"Cancer immunotherapies: from efficacy to resistance mechanisms - not only checkpoint matters","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.abb.2026.110762_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.abb.2026.110762_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168691","article-title":"TNFalpha and immune checkpoint inhibition: friend or foe for lung cancer?","volume":"22","author":"Benoot","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.abb.2026.110762_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136741","article-title":"MHC class I deficiency in solid tumors and therapeutic strategies to overcome it","volume":"22","author":"Shklovskaya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","article-title":"Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13000-021-01151-x","article-title":"PD-L1 immunostaining: what pathologists need to know","volume":"16","author":"Akhtar","year":"2021","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.abb.2026.110762_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296341","article-title":"PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment","volume":"14","author":"Parvez","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.abb.2026.110762_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.abb.2026.110762_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.abb.2026.110762_bib16","author":"Oliveros"},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.abb.2026.110762_bib18","article-title":"Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2026.110762_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.abb.2026.110762_bib20","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.abb.2026.110762_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","article-title":"Endoplasmic reticulum stress in immunity","volume":"33","author":"Bettigole","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13578-023-01073-9","article-title":"Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms","volume":"13","author":"Wang","year":"2023","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.abb.2026.110762_bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.abb.2026.110762_bib24","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/0008-5472.CAN-16-2359","article-title":"Amplification of EGFR wild-type alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors","volume":"77","author":"Nukaga","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.abb.2026.110762_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.abb.2026.110762_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.abb.2026.110762_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/carcin\/bgab075","article-title":"JAK\/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance","volume":"42","author":"Sabaawy","year":"2021","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12890-021-01553-z","article-title":"EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation","volume":"21","author":"Li","year":"2021","journal-title":"BMC Pulm. Med."},{"issue":"16","key":"10.1016\/j.abb.2026.110762_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14164055","article-title":"TNF receptor associated factor 2 (TRAF2) signaling in cancer","volume":"14","author":"Siegmund","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.abb.2026.110762_bib31","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamcr.2014.01.009","article-title":"The role of MAPK signalling pathways in the response to endoplasmic reticulum stress","volume":"1843","author":"Darling","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12964-024-01470-8","article-title":"Tumorous IRE1alpha facilitates CD8(+)T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.abb.2026.110762_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","article-title":"Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer","volume":"168","author":"Cubillos-Ruiz","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.abb.2026.110762_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41568-020-00322-0","article-title":"Antitumour immunity regulated by aberrant ERBB family signalling","volume":"21","author":"Kumagai","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12935-022-02550-w","article-title":"KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma","volume":"22","author":"Gao","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib36","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41598-018-38068-3","article-title":"Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC","volume":"9","author":"Jiang","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.abb.2026.110762_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.abb.2026.110762_bib38","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1158\/1078-0432.CCR-19-2027","article-title":"Impact of EGFR-TKI treatment on the tumor immune microenvironment in EGFR mutation-positive non-small cell lung cancer","volume":"26","author":"Isomoto","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.abb.2026.110762_bib39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/2326-6066.CIR-16-0177","article-title":"Kinase regulation of human MHC class I molecule expression on cancer cells","volume":"4","author":"Brea","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.abb.2026.110762_bib40","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.178.6.3612","article-title":"Stimulation of an unfolded protein response impairs MHC class I expression","volume":"178","author":"de Almeida","year":"2007","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.abb.2026.110762_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cllc.2022.07.003","article-title":"Association between survival and very high versus high PD-L1 expression in patients receiving pembrolizumab as first-line treatment for advanced non-small cell lung cancer","volume":"23","author":"Shah","year":"2022","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.abb.2026.110762_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008818","article-title":"Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy","volume":"12","author":"Qin","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.abb.2026.110762_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009165","article-title":"Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect","volume":"12","author":"Lu","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.abb.2026.110762_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pccm.2024.08.002","article-title":"Overcoming EGFR-TKI resistance by targeting the tumor microenvironment","volume":"2","author":"Zhang","year":"2024","journal-title":"Chin. Med. J. Pulm Crit. Care. Med."},{"key":"10.1016\/j.abb.2026.110762_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-gamma in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.abb.2026.110762_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"14","key":"10.1016\/j.abb.2026.110762_bib47","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/jnci\/djr216","article-title":"Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer","volume":"103","author":"Pine","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"415","key":"10.1016\/j.abb.2026.110762_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4307","article-title":"Stress hormones promote EGFR inhibitor resistance in NSCLC: implications for combinations with beta-blockers","volume":"9","author":"Nilsson","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.abb.2026.110762_bib49","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1078-0432.CCR-22-3379","article-title":"IL6 mediates suppression of T- and NK-cell function in EMT-associated TKI-resistant EGFR-mutant NSCLC","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.abb.2026.110762_bib50","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1158\/1535-7163.MCT-12-0311","article-title":"Activation of IL-6R\/JAK1\/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation","volume":"11","author":"Kim","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"issue":"9","key":"10.1016\/j.abb.2026.110762_bib51","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41416-019-0444-3","article-title":"Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer","volume":"120","author":"Heim","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.abb.2026.110762_bib52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41416-020-01037-7","article-title":"Differential association of CD68(+) and CD163(+) macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma","volume":"123","author":"Tremble","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.abb.2026.110762_bib53","article-title":"IL-35 regulates the function of immune cells in tumor microenvironment","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.abb.2026.110762_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757669","article-title":"A chaperone-like role for EBI3 in collaboration with calnexin under inflammatory conditions","volume":"12","author":"Watanabe","year":"2021","journal-title":"Front. Immunol."},{"issue":"W1","key":"10.1016\/j.abb.2026.110762_bib55","doi-asserted-by":"crossref","first-page":"W45","DOI":"10.1093\/nar\/gkae358","article-title":"ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data","volume":"52","author":"Zou","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.abb.2026.110762_bib56","doi-asserted-by":"crossref","first-page":"W175","DOI":"10.1093\/nar\/gkac199","article-title":"ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data","volume":"50","author":"Zou","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.abb.2026.110762_bib57","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846255","article-title":"ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data","volume":"19","author":"Oki","year":"2018","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.abb.2026.110762_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.taap.2015.08.008","article-title":"Identification of protein expression alterations in gefitinib-resistant human lung adenocarcinoma: PCNT and mPR play key roles in the development of gefitinib-associated resistance","volume":"288","author":"Lin","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.abb.2026.110762_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109249","article-title":"TGF-beta1 signaling protects retinal ganglion cells from oxidative stress via modulation of the HO-1\/Nrf2 pathway","volume":"331","author":"Chen","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2026.110762_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918794622","article-title":"Upregulation of LGALS1 is associated with oral cancer metastasis","volume":"10","author":"Li","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"15","key":"10.1016\/j.abb.2026.110762_bib61","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.abb.2026.110762_bib62","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1039\/C2MB25331C","article-title":"High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy","volume":"8","author":"Chen","year":"2012","journal-title":"Mol. Biosyst."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:49:20Z","timestamp":1774007360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S0003986126000330"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110762","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR and IRE1\u03b1 pathways are associated with distinct immunomodulatory gene expression profiles in NSCLC cells with acquired resistance to EGFR TKIs","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110762"}}